These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18606378)

  • 1. Enhanced level of micronuclei in peripheral blood lymphocytes of patients treated for restenosis with 32P endovascular brachytherapy.
    Wojcik A; Buraczewska I; Sommer S; Brzozowska K; Pregowski J; Witkowski A; Garmol D; Pszona S; Bulski W
    Cardiovasc Revasc Med; 2008; 9(3):149-55. PubMed ID: 18606378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of intracoronary brachytherapy on long-term patency of previously chronically occluded bypass graft--a case report].
    Chyrchel M; Dudek D; Heba G; Bartuś S; Rzeszutko Ł; Legutko J; Dubiel JS
    Kardiol Pol; 2004 Nov; 61(11):475-9. PubMed ID: 15883597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular brachytherapy for patients with drug-eluting stent restenosis.
    Bonello L; Kaneshige K; De Labriolle A; Roy P; Lemesle G; Torguson R; Satler LF; Pichard AD; Lindsay J; Waksman R
    J Interv Cardiol; 2008 Dec; 21(6):528-34. PubMed ID: 18973502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular radiotherapy for stenosis after percutaneous transluminal coronary angioplasty.
    Ulutin HC; Pak Y
    Radiat Med; 2001; 19(4):175-9. PubMed ID: 11550716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta endovascular brachytherapy using CO2-filled centering catheter for treatment of recurrent superficial femoropopliteal artery disease.
    Pokrajac B; Kirisits C; Schmid R; Schillinger M; Berger D; Peer K; Tripuraneni P; Pötter R; Minar E
    Cardiovasc Revasc Med; 2009; 10(3):162-5. PubMed ID: 19595397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular brachytherapy for the prevention of restenosis.
    Wilenzick RM; Kuske RR; Jenkins S
    J Invasive Cardiol; 1999 Feb; 11(2):90-2. PubMed ID: 10745489
    [No Abstract]   [Full Text] [Related]  

  • 7. Considerations on radiation source selection and utilization in vascular brachytherapy.
    Crocker I
    J Invasive Cardiol; 2003 Nov; 15(11):664-7; quiz 668. PubMed ID: 14608142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary brachytherapy: Initial Australasian experience with the Novoste Beta-Cath system.
    Brieger D; Chow C; Kuanprasert S; Adams M; Bernstein L; Harris P; Bailey B
    Heart Lung Circ; 2002; 11(3):162-6. PubMed ID: 16352092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry study for beta-radiation treatment of in-stent restenosis.
    Chu CH; Hsieh BT; Chen IJ; Chen WL; Lin UT
    Radiat Prot Dosimetry; 2009 Feb; 134(1):49-54. PubMed ID: 19376885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha particle vascular brachytherapy in the treatment of in-stent Restenosis.
    Mehdizadeh A; Fazelzadeh A; Karimi H
    Int J Cardiol; 2009 Aug; 136(2):220-1. PubMed ID: 18625530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher platelet activity is present in patients with restenosis after percutaneous coronary intervention compared with patients with an occlusion of coronary artery bypass graft.
    Osmancik PP; Bednar F; Pavkova L; Tousek P; Stros P; Jirasek K
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):807-12. PubMed ID: 19002048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic and intravascular ultrasound assessment of immediate and 9-month efficacy of percutaneous transluminal renal artery balloon angioplasty with subsequent brachytherapy in patients with renovascular hypertension.
    Lekston A; Chudek J; Gasior M; Wilczek K; Wiecek A; Kokot F; Gierlotka M; Niklewski T; Fijałkowski M; Szyguła-Jurkiewicz B; Wojnicz R; Białas B; Osuch M; Maciejewski B; Poloński L
    Kidney Blood Press Res; 2008; 31(5):291-8. PubMed ID: 18772602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micronuclei frequency in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy and its relationship with metastasis.
    Joseph LJ; Bhartiya US; Raut YS; Kand P; Hawaldar RW; Nair N
    Mutat Res; 2009 Apr; 675(1-2):35-40. PubMed ID: 19386245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous frequency of micronuclei among the newborns from high level natural radiation areas of Kerala in the southwest coast of India.
    Das B; Karuppasamy CV
    Int J Radiat Biol; 2009 Mar; 85(3):272-80. PubMed ID: 19296343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-induced micronucleus frequencies in female peripheral blood lymphocytes collected during the first and second half of the menstrual cycle.
    Krol M; Lankoff A; Buraczewska I; Derezinska E; Wojcik A
    Radiat Prot Dosimetry; 2007; 123(4):483-9. PubMed ID: 17213220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary revascularisation following intracoronary brachytherapy.
    Sabaté M
    EuroIntervention; 2009 May; 5 Suppl D():D121-6. PubMed ID: 19736060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular brachytherapy: a landmark chapter in the field of interventional cardiology.
    Waksman R
    EuroIntervention; 2011 Jan; 6(6):669-71. PubMed ID: 21205586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.